Direct correlation between DNA repair capacity and metastatic potential of K-1735 murine melanoma cells

Journal of Investigative Dermatology

Volumn 108, Issue 1, 1997, Pages 3-6

  Wei, Qingyi ^a,b   Cheng, Lie ^a   Xie, Keping ^a   Bucana, Corazon D ^a   Dong, Zhongyun ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

DNA repair; Melanoma; Metastasis

Indexed keywords

ANIMAL CELL; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; MELANOMA CELL; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; ULTRAVIOLET RADIATION;

EID: 0031014772     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12285608     Document Type: Article

References (46)

1. Albino AP, Vidal MJ, McNutt NS, Shea CR, Prieto VG, Nanus DM, Palmer JM, Hayward NK: Mutation and expression of p53 gene in human malignant melanoma. Melanoma Res 4:35-45, 1995
2. Ananthaswamy H, Pierceall WE: Molecular mechanisms of ultraviolet radiation carcinogenesis. Photochem Photobiol 52:1119-1136, 1990
3. American Cancer Society: Cancer Statistics. American Cancer Society. Atlanta, GA 1996
4. Athas AF, Hedayati M, Matanoski GM, Farmer ER, Grossman L: Development and field-test validation of an assay for DNA repair in circulating human lymphocytes. Cancer Res 51:5786-5793, 1991
5. Aukerman SL, Fidler IJ: The heterogeneous nature of metastatic neoplasms: relevance to biotherapy. In: Oldham RK (ed.), Principles of Cancer Biotherapy. Marcel Dekker, New York, 1991, pp 23-53
6. Bishop JM: Molecular themes in oncogenesis. Cell 64:235-248, 1991
7. Chalmers AH, Lavin M, Ationtornkul S, Mansbridge J, Kinson C: Resistance of human melanoma cells to radiation. Cancer Res 36:1930-1934, 1976
8. Cifone M, Fidler IJ. Increasing metastatic potential is associated with increasing genetic instability of clones isolated from murine neoplasms. Proc Natl Acad Sci USA 78:6949-6952, 1981
9. Dabholkar M, Bostick-Bruton F, Weber C, Bohr V, Egwuagu C, Reed E: ERCC1 and ERCC2 expression in malignant tissue from ovarian cancer patients. J Natl Cancer Inst 84:1512-1517, 1992
10. Dong Z, Radinsky R, Fan D, Tsan R, Bucana CD, Wilmanns C, Fidler IJ: Organ-specific modulation of steady-state mdr-1 gene expression and drug resistance in murine colon cancer cells. J Natl Cancer Inst 86:913-920, 1994a
11. Dong Z, Staroselsky AH, Qi X, Xie K, Fidler IJ: Inverse correlation between expression of inducible nitric oxide synthase activity and production of metastasis in K-1735 murine melanoma cells. Cancer Res 54:789-793, 1994b
12. Fidler IJ, Gruys MA, Cifone MA, Barnes Z, Bucana C: Demonstration of multiple phenotypic diversity in a murine melanoma of recent origin. J Natl Cancer Inst 67:947-956, 1981
13. Fidler IJ, Wilmanns C, Staroselsky A, Radinsky R, Dong Z, Fan D: Modulation of tumor cell response chemotherapy by the organ environment. Cancer Metastasis Rev 13:209-222, 1994
14. Fidler IJ: Critical factors in the biology of human cancer metastasis. Cancer Res 50:6130-6138, 1990
15. Fidler IJ: Macrophages and metastases - a biological approach to cancer therapy. Cancer Res 45:4714-4726, 1985
16. Fidler IJ: Modulation of the organ microenvironment for the treatment of cancer metastasis (commentary). J Natl Cancer Inst 87:1588-1592, 1995
17. Fidler IJ: Tumor heterogeneity and the biology of cancer invasion and metastasis. Cancer Res 38:2651-2660, 1978
18. Friedberg EC: DNA Repair. Freedman and Company, New York, 1985
19. Geleziunas R., McQuillan A, Malapetsa A, Hutchinson M, Kopriva D, Wainberg MA, Hiscott J, Bramson J, Panasci L: Increased DNA synthesis and repair-enzyme expression in lymphocytes from patients with chronic lymphocytic leukemia resistant to nitrogen mustards. J Nucl Cancer Inst 83:557-564, 1991
20. Good M, Lavin M, Chen P, Kidson C: Dependence on cloning method of survival of human melanoma cells after ultraviolet and ionizing radiation. Cancer Res 38:4671-4675, 1978
21. Hatton DH, Mitchell DL, Strickland PT, Johnson RT: Enhanced photoproduct repair: its role in the DNA damage-resistance phenotype of human malignant melanoma cells. Cancer Res 55:181-189, 1995
22. Hoy CA, Thompson LH, Mooney CL, Salazar EP: Defective DNA cross-link removal in Chinese hamster cell mutant hypersensitive to bifunctional alkylation agents. Cancer Res 45:1737-1743, 1985
23. Kripke ML: Speculations on the role of ultraviolet radiation in the development of malignant melanoma. J Natl Cancer Inst 63:541-548, 1979
24. Modrich P: Mismatch repair, genetic stability, and cancer. Science 266:1959-1960, 1994
25. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63, 1983
26. Musk P, Parons PG: Resistance of pigmented human cells to killing by sunlight and oxygen radical. Photochem Photobiol 46:489-494, 1987
27. Nicolson GL: Tumor cell instability, diversification, and progression to the metastatic phenotype: from oncogene to oncofetal expression. Cancer Res 47:1473-1487, 1987
28. Nie ZR, Paterson J, Alpert L, Tsao MS., Viallet J, Alaoui-Jamali MA: Elevated DNA repair capacity is associated with intrinsic resistance of lung cancer to chemotherapy. Cancer Res 55:4760-4764, 1995
29. Nowell PC: Mechanisms of tumor progression. Cancer Res 46:2203-2207, 1986
30. Peris K, Keller G, Chimenti S, Amantea A, Kerl H, Höfler H: Microsatellite instability and loss of heterozygosity in melanoma. J Invest Dermatol 105:625-628, 1995
31. Pinkel D, Straume T, Gray JW: Cytogenetic analysis using quantitative, high sensitivity, fluorescence hybridization. Proc Natl Acad Sci USA 83:2934-2938, 1986
32. Protic-Sabljic M, Kraemer KH: Reduced repair of non-dimer photoproducts in a gene transfected into xeroderma pigmentosum cells. Photochem Photobiol 43:509-513, 1986
33. Sancar A: Mechanisms of DNA excision repair. Science 266:1954-1958, 1994
34. Simpson-Herren L, Noker PE, Wagoner SD: Variability of tumor response to chemotherapy. I. Contribution of host heterogeneity. Cancer Chemother Pharmacol 20:297-304, 1987
35. Sparrow LE, Soong R, Dawkins HJS, Iacopetta BJ, Heenan PJ: p53 Gene mutation and expression in naevi and melanomas. Melanoma Res 5:93-100, 1995
36. Staroselsky AH, Pathak S, Chernajovsky Y, Tucker SI, Fidler IJ: Predominance of the metastatic phenotype in somatic cell hybrids of the K-1735 murine melanoma. Cancer Res 51:6292-6298, 1991
37. Talmadge JE, Fidler IJ: Enhanced metastatic potential of tumor cells harvested from spontaneous metastases of heterogeneous murine tumors. J Natl Cancer Inst 69:975-980, 1982a
38. Talmadge JE, Wolman SR, Fidler IJ: Evidence for the clonal origin of spontaneous metastases. Science 217:361-363, 1982b
39. Trope C: Different sensitivity to cytostatic drugs of primary tumor and metastasis of the Lewis carcinoma. Neoplasma 22:171-180, 1975
40. Tsuruo T, Fidler IJ: Differences in drug sensitivity among tumor cells from parental tumors, selected variants, and spontaneous metastases. Cancer Res 41:3058-3064, 1981
41. Usmani BA: Genomic instability and metastatic progression. Pathobiology 61:109-116, 1993a
42. Usmani BA, Lunec J, Sherbet GV: DNA repair and repair fidelity in metastatic variant of the B16 murine melanoma. J Cell Biochem 51:336-344, 1993b
43. Vidal MJ, Loganzo F Jr, de Oliveria AR, Hayward NK, Albino AP: Mutations and defective expression of the WAF1 p21 tumor-suppressor gene in malignant melanoma. Melonoma Res 5:243-250, 1995
44. Wei Q, Matanoski GM, Farmer BR, Hedayati M, Grossman L: DNA repair and aging in basal cell carcinoma: a molecular epidemiologic study. Proc Natl Acad Sci USA 90:1614-1618, 1993
45. Wei Q, Strom SS, Cheng L, Lee JK, Duvic M, Weber RS, Hankins PD: Reduced DNA repair capacity in patients with cutaneous malignant melanoma. Proc Am Assoc Cancer Res 37:263, 1996
46. Weichselbaum RR, Dahlberg W, Little JB: Inherently radioresistant cells exist in some human tumors. Proc Natl Acad Sci USA 82:4732-4735, 1985